C4 Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +10.4% | +55.3% | +37.9% | -32.1% | -33.3% | +71.4% | +1.0% | |
| – | +66.7% | +64.6% | -96.3% | +160.5% | +2.2% | +2.0% | +1.0% | |
| – | – | -311.6% | – | -32.1% | -58.1% | +173.3% | -21.4% | |
| – | +68.1% | +63.2% | +20.7% | +24.5% | -0.1% | -6.0% | -5.8% | |
| – | +22.5% | +73.3% | +118.7% | +28.7% | -1.7% | +0.1% | -14.1% | |
| – | +59.0% | -73.2% | +741.4% | +25.6% | -5.3% | +2.1% | -14.7% | |
| – | – | – | – | – | – | – | – | |
| – | – | -43.0% | +74.5% | +3.3% | -38.0% | -100.0% | – | |
| – | – | – | – | – | – | – | – | |
| – | +18.6% | -22.1% | +242.7% | -178.1% | – | -89.8% | -7.6% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.